- Corporate Officers - B
- Buchi J Kevin
Insider Trading History of Buchi J Kevin
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Buchi J Kevin since 2006.
This trader's CIK number is 1209726.
At the time of last reporting, Buchi J Kevin was the Director of Amneal Pharmaceuticals, Inc.. (stock ticker symbol AMRX).
Also see all insider trading activities at Amneal Pharmaceuticals, Inc..
Note that in the past
BUCHI J KEVIN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Stemline Therapeutics Inc (STML) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | STML | 500 | $5,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | DRNA | 0 | $0 | 0 | $0 | 4,666 | $0 |
Yearly summary of insider trading at Tetralogic Pharmaceuticals Corp (TLOG) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | TLOG | 10,000 | $46,329 | 0 | $0 | 0 | $0 |
| 2014 | TLOG | 35,000 | $167,479 | 0 | $0 | 0 | $0 |
| 2013 | TLOG | 285,714 | $1,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ampio Pharmaceuticals, Inc. (AMPE) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | AMPE | 146,858 | $38,991 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cephalon Inc (CEPH) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | CEPH | 0 | $0 | 15,000 | $1,114,200 | 0 | $0 |
| 2007 | CEPH | 0 | $0 | 20,000 | $1,520,060 | 0 | $0 |
| 2006 | CEPH | 0 | $0 | 58,684 | $4,253,289 | 30,000 | $1,533,750 |
| 2006 | CEPH | 0 | $0 | 29,073 | $2,163,118 | 29,073 | $445,776 |
Yearly summary of insider trading at Amneal Pharmaceuticals, Inc. (AMRX) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AMRX | 0 | $0 | 0 | $0 | 40,258 | $0 |
| 2024 | AMRX | 0 | $0 | 0 | $0 | 76,453 | $0 |
| 2023 | AMRX | 0 | $0 | 0 | $0 | 80,128 | $0 |
| 2022 | AMRX | 0 | $0 | 0 | $0 | 35,406 | $0 |
| 2020 | AMRX | 0 | $0 | 0 | $0 | 6,459 | $0 |
| 2019 | AMRX | 0 | $0 | 0 | $0 | 6,107 | $0 |
Yearly summary of insider trading at Benitec Biopharma Inc. (BNTC) by Buchi J Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | BNTC | 0 | $0 | 0 | $0 | 51,813 | $199,998 |
| 2023 | BNTC | 51,813 | $0 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Buchi J Kevin:
1. Stemline Therapeutics Inc (STML)
2. Dicerna Pharmaceuticals Inc (DRNA)
3. Tetralogic Pharmaceuticals Corp (TLOG)
4. Ampio Pharmaceuticals, Inc. (AMPE)
5. Cephalon Inc (CEPH)
6. Amneal Pharmaceuticals, Inc. (AMRX)
7. Benitec Biopharma Inc. (BNTC)
Table 1. Insider trading of Stemline Therapeutics Inc (STML) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-01-29 | STML | Buy | 500 | 10.00 | 5,000 |
Table 2. Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-03 | DRNA | Option Ex | 4,666 | .00 | 0 |
Table 3. Insider trading of Tetralogic Pharmaceuticals Corp (TLOG) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-26 | TLOG | Buy | 5,000 | 4.23 | 21,150 |
| 2015-01-07 | TLOG | Buy | 5,000 | 5.04 | 25,179 |
| 2014-12-09 | TLOG | Buy | 5,000 | 6.01 | 30,059 |
| 2014-12-02 | TLOG | Buy | 10,000 | 4.99 | 49,900 |
| 2014-11-18 | TLOG | Buy | 10,000 | 4.82 | 48,190 |
| 2014-11-11 | TLOG | Buy | 10,000 | 3.93 | 39,330 |
| 2013-12-17 | TLOG | Buy | 285,714 | 7.00 | 1,999,998 |
Table 4. Insider trading of Ampio Pharmaceuticals, Inc. (AMPE) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-09 | AMPE | Buy | 21,858 | .29 | 6,295 |
| 2023-06-08 | AMPE | Buy | 25,000 | .30 | 7,400 |
| 2023-05-16 | AMPE | Buy | 32,534 | .27 | 8,914 |
| 2023-05-15 | AMPE | Buy | 44,026 | .25 | 10,874 |
| 2023-05-12 | AMPE | Buy | 23,440 | .23 | 5,508 |
Table 5. Insider trading of Cephalon Inc (CEPH) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-02-17 | CEPH | Sale | 28,684 | 74.40 | 2,134,089 |
| 2010-03-05 | CEPH | Option Ex | 30,000 | 51.12 | 1,533,750 |
| 2010-03-05 | CEPH | Sale | 30,000 | 70.64 | 2,119,200 |
| 2008-12-03 | CEPH | Sale | 15,000 | 74.28 | 1,114,200 |
| 2007-12-06 | CEPH | Sale | 20,000 | 76.00 | 1,520,060 |
| 2006-02-17 | CEPH | Option Ex | 29,073 | 15.33 | 445,776 |
| 2006-02-17 | CEPH | Sale | 29,073 | 74.40 | 2,163,118 |
Table 6. Insider trading of Amneal Pharmaceuticals, Inc. (AMRX) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-05 | AMRX | Option Ex | 40,258 | .00 | 0 |
| 2024-05-10 | AMRX | Option Ex | 76,453 | .00 | 0 |
| 2023-05-10 | AMRX | Option Ex | 80,128 | .00 | 0 |
| 2022-05-08 | AMRX | Option Ex | 35,406 | .00 | 0 |
| 2020-05-07 | AMRX | Option Ex | 6,459 | .00 | 0 |
| 2019-05-08 | AMRX | Option Ex | 6,107 | .00 | 0 |
Table 7. Insider trading of Benitec Biopharma Inc. (BNTC) by Buchi J Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-27 | BNTC | Option Ex | 51,813 | 3.86 | 199,998 |
| 2023-08-11 | BNTC | Buy | 51,813 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Buchi J Kevin
(Director of Amneal Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.